Neuraxis, INC

Neuraxis, Inc.

Biotechnology • Healthcare • Carmel, IN, United States • NRXS (ASE)

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

812 689 0791 11611 North Meridian St, Carmel, IN 46032, United States Wikipedia

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Stock Market Today: Stock Market News And Analysis - Investor's Business Daily
Investor's Business Daily • Jan 5
Stock Market News for Jan 5, 2026 - Stock Titan
Stock Titan • Jan 6
Stock Market News for Jan 2, 2026 - Yahoo Finance
Yahoo Finance • Jan 2
Stock market ends 2025 with double-digit gains - ABC News
ABC News • Dec 31
The Stock Market Sounds an Alarm as Investors Get Bad News About President Trump's Tariffs. History Says the S&P 500 Will Do This in 2026. - The Motley Fool
The Motley Fool • Jan 2

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Neuraxis, INC had layoffs?
No layoff events have been recorded for Neuraxis, INC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Neuraxis, INC have?
Neuraxis, INC has approximately 21 employees.
What industry is Neuraxis, INC in?
Neuraxis, INC operates in the Biotechnology industry, within the Healthcare sector.
Is Neuraxis, INC a publicly traded company?
Yes, Neuraxis, INC is publicly traded under the ticker symbol NRXS on the ASE. The company has a market capitalization of approximately $0.04 billion.
Where is Neuraxis, INC headquartered?
Neuraxis, INC is headquartered in Carmel, IN, United States at 11611 North Meridian St, Carmel, IN 46032, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.